Korro Bio, Inc.
Korro Bio, Inc. (KKR) — Form 10-Q: Quarterly report
AI-generated summary
Korro Bio, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The report details the company's financial results and operations across its asset management, insurance, and strategic holdings segments. Total revenues and expenses for the period reflect ongoing investment activities and market conditions.
Key facts
- Document
- 10-Q
More KKR filings
- 8-K
Filed Nov 9, 2026
- 8-K
Filed Nov 4, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Oct 26, 2026
- 3
Filed Oct 26, 2026
- 8-K
Filed Oct 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.